Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

PACS vs BTSG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PACS Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

PACS Overall Winner 6-Pillar Tally: PACS 4 – 2 BTSG Matrix Metrics: PACS 8 – 2 BTSG

As of Nov 20, 2026, PACS Group, Inc. (PACS) is the stronger overall head-to-head candidate over BrightSpring Health Services, Inc. (BTSG) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). PACS carries a Unified Composite Score of 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin), whereas BTSG carries 42.6/100 (HOLD) at $62.84 (25.9x Forward P/E, 3.5% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PACS vs BTSG
PACS NYSE Head-to-Head Winner
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap $6.8B
TTM Revenue $5.71B
Forward P/E 15.3x
Beta / 30D Vol 0.78β · 51% Vol
Unified Composite Score
46.8 / 100 HOLD
Tech 35.0 Fund 48.0 Flow 62.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.2 · SMA20: $48.01 · SMA50: $45.43
BTSG NASDAQ
BrightSpring Health Services, Inc. Common Stock
Services-Home Health Care Services
$62.84
-1.84% 1D
Market Cap $12.7B
TTM Revenue $10.4B
Forward P/E 25.9x
Beta / 30D Vol 0.94β · 59% Vol
Unified Composite Score
42.6 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.1 · SMA20: $66.80 · SMA50: $62.62

6-Pillar Scorecard Institutional Category Breakdown (PACS 4 – 2 BTSG)

Columns: Metric · PACS · BTSG
1. Valuation Multiples PACS
Forward P/E 15.3x 25.9x
Trailing P/E 26.2x 45.4x
PEG Ratio 1.22x N/M
EV / Revenue 1.8x 1.3x
2. Growth & Scale BTSG
Revenue Growth (YoY) +11.5% +26.4%
Earnings Growth (YoY) +15.6% +82.0%
TTM Revenue (USD) $5.71B $10.4B
Market Cap $6.8B $12.7B
3. Profitability & Quality PACS
Gross Margin 17.8% 12.5%
Operating Margin 7.4% 3.5%
Net Profit Margin 4.9% 2.7%
Return on Equity (ROE) 26.5% 15.5%
4. Balance Sheet & Cash Flow BTSG
Cash Generation (TTM) $8.2M $337M
Cash Flow Margin 0.1% 3.2%
Net Cash / Leverage $3.29B Net Debt (2.81x D/E) $1.14B Net Debt (1.09x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning PACS
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 46.1% (11th %ile) 152.7% (100th %ile)
Put/Call OI Skew 0.52x (Call-Skewed) 1.69x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat PACS
OpEx & R&D Intensity 10.4% of Rev ($593M) 9.0% of Rev ($939M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PACS (8) vs BTSG (2)
Institutional Metric PACS BTSG Criterion Row Edge
Market Capitalization
Scale
$6.8B $12.7B Larger Scale BTSG
Trailing P/E Ratio
Valuation
26.2x 45.4x Lower Multiple PACS
Forward P/E Ratio
Valuation
15.3x 25.9x Lower Multiple PACS
Revenue Growth (YoY)
Growth
+11.5% +26.4% Higher Growth BTSG
Operating Margin (TTM)
Profitability
7.4% 3.5% Higher Margin PACS
Net Profit Margin
Profitability
4.9% 2.7% Higher Margin PACS
Return on Equity (ROE)
Capital Efficiency
26.5% 15.5% Higher ROE PACS
52-Week Range Position
Momentum
79% ($14–$52) 74% ($31–$74) Stronger Trend PACS
Beta / 30D Volatility
Risk Regime
0.78β · 51% Vol 0.94β · 59% Vol Lower Realized Risk PACS
Unified Institutional Score
Composite Signal
46.8 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite PACS
Trailing 12M Revenue (USD)
Operating Scale
$5.71B $10.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.8% 12.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.22x PEG · 1.8x EV/Rev N/M PEG · 1.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$8.2M ($3.29B Net Debt (2.81x D/E)) $337M ($1.14B Net Debt (1.09x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BTSG +11.31 pp
PACS: -8.06% · BTSG: +3.25%
3M Horizon BTSG +6.94 pp
PACS: -1.31% · BTSG: +5.63%
6M Horizon PACS +8.26 pp
PACS: +15.68% · BTSG: +7.42%
1Y Horizon PACS +64.69 pp
PACS: +159.48% · BTSG: +94.79%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period PACS Revenue BTSG Revenue PACS Op. Margin BTSG Op. Margin Margin Leader
FY2022 $2.40B $7.72B 9.6% 2.4% PACS
FY2023 $3.11B $7.69B 6.7% 0.8% PACS
FY2024 $4.09B $10.1B 3.0% 1.1% PACS
FY2025 $5.29B $12.9B 5.9% 2.3% PACS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PACS CONSOLIDATION
83d in phase · OBV NEUTRAL
Current IV 46.1%
IV Percentile 11th %ile
Put/Call OI Skew 0.52x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact PACS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BTSG CONSOLIDATION
104d in phase · OBV NEUTRAL
Current IV 152.7%
IV Percentile 100th %ile
Put/Call OI Skew 1.69x (Put-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact BTSG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $49.00 · IV 47.5%

PACS vs. BTSG: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of PACS ($4,900) vs. BTSG ($6,967) against risk-defined 5-day vertical and put-wall option structures.

PACS Spot $49.00 · IV 47.5%
PACS Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $50 / $55 Bull Call Spread

Buy 1x $50C · Sell 1x $55C · 32d

Net Entry $103 Debit
T+5d @ +5% Move +$65 (+63%)
Max Risk / Buffer $103 Capped
5d Edge & Liquidity 1.1x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $45 / $40 Bull Put Spread

Sell 1x $45P · Buy 1x $40P · 32d

Net Entry $104 Credit
Max Credit / Yield +$104 (+26.3% RoM)
Max Risk / Buffer -10.3% Cushion ($396 Mgn)
5d Edge & Liquidity 73% PoP · Liq C
Simulate 5-Day Payoff →
BTSG Spot $69.67 · IV 45.1%
BTSG Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $70 / $75 Bull Call Spread

Buy 1x $70C · Sell 1x $75C · 31d

Net Entry $253 Debit
T+5d @ +5% Move +$58 (+23%)
Max Risk / Buffer $253 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $65 / $60 Bull Put Spread

Sell 1x $65P · Buy 1x $60P · 59d

Net Entry $70 Credit
Max Credit / Yield +$70 (+16.3% RoM)
Max Risk / Buffer -7.7% Cushion ($430 Mgn)
5d Edge & Liquidity 72% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PACS Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $6.8B market capitalization and 7.4% operating margin.
OpEx & R&D Reinvestment 10.4% of Rev ($593M)
90D Engineering Disclosures 0 Published
BTSG Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $12.7B market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 9.0% of Rev ($939M)
90D Engineering Disclosures 0 Published

Investor FAQ PACS vs BTSG Key Questions & Quantitative Answers

As of Nov 20, 2026, PACS Group, Inc. (PACS) is the stronger overall head-to-head candidate over BrightSpring Health Services, Inc. (BTSG) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). PACS carries a Unified Composite Score of 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin), whereas BTSG carries 42.6/100 (HOLD) at $62.84 (25.9x Forward P/E, 3.5% operating margin). Technically, PACS sits in a Neutral phase (RSI 39.2, CONSOLIDATION options structure) and BTSG sits in a Neutral phase (RSI 42.1, CONSOLIDATION options structure).

BTSG leads the Growth & Scale pillar: PACS posts +11.5% YoY revenue growth and +15.6% YoY earnings growth on $5.71B TTM revenue (17.8% gross margin, 7.4% operating margin), compared with BTSG at +26.4% YoY revenue growth and +82.0% YoY earnings growth on $10.4B TTM revenue (12.5% gross margin, 3.5% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), PACS cumulative revenue shifted +120.4% while BTSG shifted +67.2%. In operating R&D and SG&A reinvestment, PACS deploys 10.4% of Rev ($593M) (0 90-day corporate R&D disclosures) versus 9.0% of Rev ($939M) (0 disclosures) for BTSG.

PACS screens cheaper on headline valuation multiples. PACS trades at 15.3x Forward P/E, 26.2x Trailing P/E, 1.22x PEG, and 1.8x EV/Revenue (0.1% FCF margin), whereas BTSG trades at 25.9x Forward P/E, 45.4x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (3.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PACS (26.5% ROE) versus BTSG (15.5% ROE) capital efficiency.

In options market volatility and institutional positioning, PACS carries 46.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.52x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.78β · 51% Vol realized risk). By comparison, BTSG carries 152.7% implied volatility (100th %ile, Extreme (>80th %ile)), a 1.69x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.94β · 59% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.